๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas

โœ Scribed by Daniel Taussky; Pavel Dulguerov; Abdelkarim S. Allal


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
203 KB
Volume
27
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background. Definitive radiotherapy (RT) for head and neck cancer is increasingly used to preserve organ function, whereas surgery is reserved for treatment failure. However, data are sparse regarding the feasibility of salvage surgery, particularly for unselected patients after accelerated RT.

Methods. From 1991 to 2001, 297 patients, most with stage III to IV cancer (Union Internationale Contre le Cancer) were treated with concomitant boost RT (median dose, 69.9 Gy in 41 fractions) with or without chemotherapy (in 33%, usually cisplatin with or without 5-fluorouracil). The 75 patients seen with local and/or regional failure were studied. We analyzed the factors influencing the decision to attempt surgical salvage, the oncologic outcome, and the associated complications.

Results. Seventeen (23%) of the 75 patients had a salvage operation. This included all five patients with laryngeal cancers but only 16% to 20% of patients with tumors in other locations. Most patients could not be operated on because of disease extension (40%) and poor general condition/advanced age (30%). Patients with low initial primary T and N classification were more likely to undergo surgery (p = .002 and .014, respectively). Median post-recurrence survival was significantly better for patients who had salvage operations than for those without surgical salvage treatment (44 vs 11 months, p = .0001). Thirteen patients were initially seen with postop-erative complications (mostly delayed wound healing and fistula formation).

Conclusions. After definitive accelerated RT with the concomitant boost technique, only a minority of patients with local or regional recurrence underwent salvage surgery. Disease stage, tumor location, and patient's general condition at the initial diagnosis seemed to be the main factors influencing the decision to attempt surgical salvage. For patients with initially resectable disease who undergo radical nonsurgical treatment, more effective follow-up is needed to favor early detection of treatment failure, which may lead to a timely and effective salvage surgery.


๐Ÿ“œ SIMILAR VOLUMES


Salvage surgery after concomitant chemor
โœ Hiang Khoon Tan; Roland Giger; Anne Auperin; Jean Bourhis; Franรงois Janot; Steph ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 170 KB ๐Ÿ‘ 2 views

## Abstract ## Background. Salvage surgery after concomitant chemoradiation therapy (CCRT) for patients with head and neck squamous cell carcinomas (HNSCC) is challenging because of its associated morbidity/mortality and the poor prognoses of these patients. ## Methods. The outcome analysis of p

Elective neck dissection during salvage
โœ Roi Dagan; Christopher G. Morris; Jessica M. Kirwan; John W. Werning; Mikhail Va ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB

## Abstract ## Objectives/Hypothesis: To define the role of elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma (SCCA) initially treated with elective nodal irradiation (ENI). ## Study Design: Retrospective chart review. ## Methods: We re

Phase I and initial phase II results fro
โœ David L. Schwartz; R. Bruce Montgomery; Bevan Yueh; Michael Donahue; Yoshimi Anz ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND The current Phase I/II study assessed induction docetaxel/carboplatin given weekly for 4 weeks, followed by weekly docetaxel/carboplatin and concomitant boost radiotherapy (CBโ€XRT) for locally advanced head and neck squamous cell carcinoma. ## METHODS Twenty patients wi